Metastatic Breast Cancer Treatment Drug: ABRAXANE for Injectable Suspension


 

ABRAXANE® Side Effects


Black Box Warning

ABRAXANE for Injectable Suspension is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.

Understanding Safety Information About ABRAXANE®

The following side effects were reported in ABRAXANE clinical trials. Provided here is a description of these side effects and some helpful information.

Hair loss (alopecia)

Loss of eyebrows, eyelashes, pubic hair, and scalp hair may occur 14 to 21 days after you begin treatment. Your hair will grow back once the ABRAXANE treatment has ended.

  • Be gentle to your hair and scalp
  • Use low heat when using a hair dryer
  • Cut your hair short
  • Protect your scalp from the sun

Infections due to low white blood cell count (neutropenia)

White blood cells are among the body’s defenses against bacterial infections. ABRAXANE usually causes a brief drop in white blood cells, and you may be more susceptible to infection and fever. Between your treatment cycles, you will have blood tests to check your white blood cell counts.

  • Call your doctor if you experience a fever over 100.4°F
  • Wash your hands often
  • Avoid crowds and people with colds
  • Immediately clean and protect cuts
  • Check with your doctor before getting immunization shots
  • Take a bath or shower daily using mild soap
  • Use lotion to prevent your skin from cracking

Numbness, tingling, or burning of hands and feet (sensory neuropathy)

These side effects, known as sensory neuropathy, occur often and usually improve without medication within a month of completing treatment (average 22 days for severe side effects). It may be necessary to interrupt treatment with ABRAXANE until these symptoms improve, after which time treatment can be restarted at a lower dose.

  • Immediately tell your doctor about these side effects—your doctor may find it necessary to adjust the dose
  • Massage your hands and feet to stimulate nerves
  • Apply moisturizing cream/lotion to your hands and feet
  • Keep your body warm
  • Avoid activities in extreme weather
  • Avoid wearing tight footwear
  • Avoid standing for long periods of time and walk only short distances
  • Take extra precaution near fires, hot water, or other sources of heat
  • Avoid using an ice pack on any part of your body

Fatigue and weakness (asthenia)

Tiredness and weakness after treatment are known as asthenia. They often disappear without interrupting or modifying treatment.

  • Get proper rest
  • Take part in activities that relax you
  • Eat a well-balanced diet
  • Drink plenty of fluids
  • Perform light exercise daily

Joint and muscle pain

Soreness of the joints and muscles may occur shortly after treatment begins, but usually disappears within a few days.

  • Tell your doctor if you are experiencing any severe joint or muscle pain
  • Perform light exercise

Low red blood cell count (anemia)

Anemia occurs when there are not enough red blood cells in your blood. It may make you feel tired, appear pale, and experience shortness of breath. Contact your doctor if you experience any of these symptoms.

  • Talk to your doctor about medications that may increase your red blood cell count
  • Conserve energy by doing only the things that are most important to you
  • Take short naps throughout the day instead of one long nap
  • Perform light exercise
  • Get up slowly from lying or sitting positions to reduce dizziness
  • Eat small meals frequently throughout the day
  • Drink plenty of fluids

Mouth or lip sores (mucositis)

Mouth or lip sores may occur a few days after starting treatment. This side effect usually disappears within 1 week.

  • Use lip balm or another lip moisturizer
  • Use a soft toothbrush and brush your teeth after eating
  • Use mouthwash that does not contain alcohol
  • Frequently rinse your mouth with warm salt water
  • Avoid foods that might irritate your mouth, such as spicy foods, orange juice, and pretzels

Upset stomach and diarrhea

Nausea, vomiting, and/or diarrhea may occur following treatment. If you experience nausea or stomach upset, tell your doctor, because medicines can be given to reduce or eliminate these symptoms. Diarrhea will usually disappear without treatment; however, tell your doctor right away if you experience severe abdominal or stomach area pain and/or severe diarrhea.

  • Drink plenty of fluids slowly and frequently
  • Avoid drinking coffee, tea, and alcohol
  • Avoid sweets as well as fried, greasy, or spicy foods
  • Eat low-fiber foods such as eggs, potatoes, white bread, or creamed cereals
  • Avoid dairy products such as milk, cheese, or ice cream

Irritation at the injection site

You may experience discomfort, redness, swelling, inflammation, or a deep sore or break in the skin at the site of the injection.

  • Inform your doctor if you experience any irritation at the injection site

Low heart rate (bradycardia)

It is possible to experience a drop in your heart rate, but patients do not usually notice this change, which usually does not require treatment. You should tell your doctor if you have a history of heart disease.

Low blood pressure (hypotension)

If you experience dizziness, fainting, or shortness of breath, talk to your doctor.

  • Have your doctor check your blood pressure
  • Drink plenty of water
  • Exercise moderately to increase blood flow
  • Avoid heavy lifting
  • Elevate the head of your bed to improve blood circulation
  • Eat small meals frequently
  • Rest after meals to minimize dizziness
  • Avoid hot showers and baths
  • Rise slowly from sitting or lying positions

 

 

Important Safety Information & Boxed Warning

You should receive ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) under the care of a doctor who is trained to use cancer drugs. Because you may have side effects from your treatment, you should get this medicine in a clinic or hospital with doctors, nurses, and pharmacists who are trained to give cancer drugs.

ABRAXANE therapy should not be given to patients with metastatic breast cancer who have low blood counts. Low blood counts, especially low white blood cell counts, may make you more likely to get an infection. In order to check for low blood counts your doctor may need to take some blood to test your blood counts.

Note: Abraxane is paclitaxel made with the human blood protein albumin. This makes it behave differently in the body than regular paclitaxel. DO NOT SUBSTITUTE FOR OR WITH OTHER PACLITAXEL DRUGS.

Important Safety Information

One of the more important side effects associated with chemotherapy is neutropenia, which is a decrease in the number of infection-fighting white blood cells (neutrophils). Normal levels range from approximately 1,500 cells/mm3 to 1,800 cells/mm3 (but vary according to several factors, such as age and race). If levels fall below 500 cells/mm3, your risk of developing an infection increases and treatment may be interrupted. To avoid the risk of serious infection and fever, your doctor will monitor your absolute neutrophil count (ANC) during therapy.

Women should avoid becoming pregnant while being treated with ABRAXANE. Tell your doctor if you are pregnant, if you become pregnant, or you plan to become pregnant while taking ABRAXANE. Discuss with your doctor how ABRAXANE may affect fertility. Nursing a baby while taking ABRAXANE is not recommended because the drug may be present in breast milk

The most important adverse events included lower white and red blood cell counts, infections, tingling and numbness, nausea, vomiting, diarrhea, muscle and joint aches, and mouth sores. Other adverse reactions included weakness, visual disturbances, fluid retention, hair loss, and liver and kidney dysfunction. Low platelet counts, allergic reactions (which in rare cases were severe), cardiovascular reactions, and injection site reactions were uncommon.

Sensory neuropathy (numbness, tingling, or burning in the hands and feet) can occur with ABRAXANE and other paclitaxel medications. Severe sensory neuropathy can improve with proper management, as prescribed by your doctor. You should tell your nurse or doctor if you experience numbness, tingling, or burning in your hands or feet while taking ABRAXANE.

Please talk to your doctor or nurse if you have questions regarding the potential side effects of ABRAXANE therapy. You may want to review the Product Information, including Warnings, Precautions, and Contraindications.

The information on this site is intended for US residents only.

©2008 Abraxis BioScience, Inc.
and AstraZeneca Pharmaceuticals LP.
All Rights Reserved. AO 711/256325  2/08

ABRAXANE is marketed under a
co-promotion agreement between
Abraxis BioScience, Inc. and AstraZeneca.

Abraxis
AstraZeneca

Abraxis Oncology is a division of Abraxis
BioScience, Inc. All Abraxis BioScience,
Inc. corporate names, names of services,
and names of products referred to herein
are trade names, service marks, and/or
trademarks that are owned by or licensed
to Abraxis BioScience, its divisions or its
affiliates, unless otherwise noted.

Important Safety Information & Boxed Warning

You should receive ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) under the care of a doctor who is trained to use cancer drugs. Because you may have side effects from your treatment, you should get this medicine in a clinic or hospital with doctors, nurses, and pharmacists who are trained to give cancer drugs.

ABRAXANE therapy should not be given to patients with metastatic breast cancer who have low blood counts. Low blood counts, especially low white blood cell counts, may make you more likely to get an infection. In order to check for low blood counts your doctor may need to take some blood to test your blood counts.

Note: Abraxane is paclitaxel made with the human blood protein albumin. This makes it behave differently in the body than regular paclitaxel. DO NOT SUBSTITUTE FOR OR WITH OTHER PACLITAXEL DRUGS.

Important Safety Information

One of the more important side effects associated with chemotherapy is neutropenia, which is a decrease in the number of infection-fighting white blood cells (neutrophils). Normal levels range from approximately 1,500 cells/mm3 to 1,800 cells/mm3 (but vary according to several factors, such as age and race). If levels fall below 500 cells/mm3, your risk of developing an infection increases and treatment may be interrupted. To avoid the risk of serious infection and fever, your doctor will monitor your absolute neutrophil count (ANC) during therapy.

Women should avoid becoming pregnant while being treated with ABRAXANE. Tell your doctor if you are pregnant, if you become pregnant, or you plan to become pregnant while taking ABRAXANE. Discuss with your doctor how ABRAXANE may affect fertility. Nursing a baby while taking ABRAXANE is not recommended because the drug may be present in breast milk

The most important adverse events included lower white and red blood cell counts, infections, tingling and numbness, nausea, vomiting, diarrhea, muscle and joint aches, and mouth sores. Other adverse reactions included weakness, visual disturbances, fluid retention, hair loss, and liver and kidney dysfunction. Low platelet counts, allergic reactions (which in rare cases were severe), cardiovascular reactions, and injection site reactions were uncommon.

Sensory neuropathy (numbness, tingling, or burning in the hands and feet) can occur with ABRAXANE and other paclitaxel medications. Severe sensory neuropathy can improve with proper management, as prescribed by your doctor. You should tell your nurse or doctor if you experience numbness, tingling, or burning in your hands or feet while taking ABRAXANE.

Please talk to your doctor or nurse if you have questions regarding the potential side effects of ABRAXANE therapy. You may want to review the Product Information, including Warnings, Precautions, and Contraindications.

The information on this site is intended for US residents only.

©2008 Abraxis BioScience, Inc. and AstraZeneca Pharmaceuticals LP. All Rights Reserved. AO 711/256325  2/08
(Site updated 2/07)

ABRAXANE is marketed under a co-promotion agreement between Abraxis BioScience, Inc. and AstraZeneca.

Abraxis
AstraZeneca

Abraxis Oncology is a division of Abraxis BioScience, Inc. All Abraxis BioScience, Inc. corporate names, names of services, and names of products referred to herein are trade names, service marks, and/or trademarks that are owned by or licensed to Abraxis BioScience, its divisions or its affiliates, unless otherwise noted.